Is JVInvest stock valuation data free and transparent?

Yes, all valuation data on JVInvest is 100% free and transparent. We provide verifiable P/E ratios for the Top 100 global stocks, S&P 500, Nasdaq 100, and major indices worldwide. All data sources are disclosed so you can verify every calculation yourself.

What valuation metrics are available on JVInvest?

JVInvest provides transparent P/E ratios for Top 100 global stocks (MSCI World), S&P 500, Nasdaq 100, DAX, FTSE 100, Nikkei 225 and more. All valuation metrics are verifiable with disclosed quarterly EPS data and market prices.

Do I need to create an account to access the data?

No account or signup is required. All S&P 500 fundamental data is freely accessible without registration.

How can I verify the P/E ratio calculations?

All our valuation data is 100% transparent. We disclose all data sources, quarterly EPS figures, and market prices used in calculations. You can verify every P/E ratio yourself using our transparent methodology.

What is a Sankey chart for stocks?

A Sankey chart visualizes the flow of money through a company's financial statements - showing how revenue flows to costs, operating income, net income, and cash flows. JVInvest offers free Sankey charts for all S&P 500 companies.

Which stock indices have free valuation data?

JVInvest provides free, verifiable valuation data for major global indices: S&P 500, Nasdaq 100, DAX 40, FTSE 100, CAC 40, Nikkei 225, and the Top 100 MSCI World stocks. All index P/E ratios are calculated transparently.

What is the current S&P 500 P/E ratio?

JVInvest calculates and displays the current S&P 500 index P/E ratio based on the aggregate earnings of all constituent companies. Visit the Valuation page for the latest P/E ratio data.

Daily Market Report – April 21, 2026

Name: Transparent Stock Valuation Data (English & German)
Creator: JVInvest
License: https://creativecommons.org/licenses/by/4.0/

Market Report – April 21, 2026

In the United States, the S&P 500 (SP:SPX) and the tech-heavy Nasdaq 100 (NASDAQ:NDX) fell by about 0.6%. In Europe, the DAX (XETR:DAX) also dropped by around 0.6%. The yield on ten-year U.S. Treasury bonds (TVC:US10Y) remained at elevated levels, while the euro against the U.S. dollar (FX:EURUSD) showed little change. New macroeconomic impulses were absent, leading investors' attention to be fully focused on the ongoing earnings season.

At the center of attention was the healthcare company UnitedHealth Group (NYSE:UNH), which exceeded market expectations with its quarterly results. The company reported an adjusted earnings per share of $7.23 on revenue of approximately $111.7 billion and simultaneously raised its earnings forecast for the full year. The stock reacted with significant price gains. It was particularly noted that the cost development in the healthcare business stabilized after rising treatment costs had recently caused uncertainty. Market participants interpreted the numbers as an indication that margins in the sector are more robust than previously feared.

In the commodity market, the oil price remained a central factor. The North Sea Brent (TVC:UKOIL) and the U.S. benchmark WTI (TVC:USOIL) were trading at elevated levels, supported by geopolitical tensions in the Middle East. Major energy companies such as Exxon Mobil (NYSE:XOM) and Chevron (NYSE:CVX) benefited from this, with their stocks showing stable performance. Gold (TVC:GOLD) moved sideways near recent highs.